Interestingly, using a theoretical-biological model that simulates the induction of LTP and of Rubinstein-Taybi syndrome (RTS)-induced LTP deficits, it was predicted that the combination of HDAC and PDE inhibitors would rescue LTP deficits in the RST model [27]. The gene discussed is HDAC9; the disease is Rubinstein-Taybi syndrome.